ArticleVeterinary world2026
Melatonin attenuates fluoride-induced neurotoxicity and cognitive dysfunction through modulation of oxidative stress, neuroinflammation, and SIRT1 signaling in Wistar rats.
Article in Veterinary world, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Chronic fluoride exposure causes neurotoxicity, oxidative stress, neuroinflammation, and cognitive impairment, posing a significant public health concern. This study investigated the neuroprotective potential of melatonin against fluoride-induced neurotoxicity and cognitive dysfunction in male and female Wistar rats, with emphasis on oxidative stress, neuroinflammation, apoptosis, and sirtuin 1 (SIRT1) signaling. Materials and Methods: Four-week-old Wistar albino rats (n=8 per group per sex) were exposed to sodium fluoride (NaF, 50 ppm in drinking water) alone or co-treated with melatonin (10 or 20 mg/kg, oral) for 8 weeks. Cognitive function was assessed using the Morris Water Maze (MWM) and Novel Object Recognition Test (NORT). Serum fluoride, brain SIRT1, oxidative stress markers (malondialdehyde [MDA], superoxide dismutase [SOD]), apoptosis markers (caspase-3, B-cell lymphoma 2 [Bcl-2]), inflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6]), acetylcholinesterase (AChE) levels, and hippocampal histopathology were evaluated. Results: NaF exposure significantly elevated serum fluoride, reduced brain SIRT1, increased oxidative stress, apoptosis, neuroinflammation, AChE activity, and caused hippocampal neuronal damage, leading to impaired learning and memory in both sexes (p < 0.05). Melatonin co-treatment (both doses) significantly attenuated these changes by lowering serum fluoride, restoring SIRT1 levels, reducing MDA, caspase-3, TNF-α, IL-6, and AChE, while increasing SOD and Bcl-2. It also improved behavioral performance in the MWM and NORT and preserved hippocampal neuronal morphology. Effects were comparable between sexes and between the two melatonin doses. Conclusion: Melatonin effectively mitigates fluoride-induced neurotoxicity and cognitive dysfunction in Wistar rats by modulating oxidative stress, neuroinflammation, apoptosis, and SIRT1 signaling. These findings highlight melatonin as a promising neuroprotective agent against environmental fluoride toxicity, with potential translational relevance for fluorosis-endemic areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.